Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $27,000 | -89.2% | 945 | -80.3% | 0.00% | – |
| Q4 2020 | $249,000 | +344.6% | 4,806 | +226.9% | 0.00% | – |
| Q3 2020 | $56,000 | -44.0% | 1,470 | -40.7% | 0.00% | – |
| Q2 2020 | $100,000 | +3233.3% | 2,477 | +2215.0% | 0.00% | – |
| Q1 2020 | $3,000 | -96.8% | 107 | -96.4% | 0.00% | – |
| Q4 2019 | $93,000 | +97.9% | 2,984 | +66.9% | 0.00% | – |
| Q3 2019 | $47,000 | +20.5% | 1,788 | +4.6% | 0.00% | – |
| Q2 2019 | $39,000 | – | 1,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |